Airway Clearance Devices For Cystic Fibrosis Market Report 2026

Airway Clearance Devices For Cystic Fibrosis Market Overview

• Airway Clearance Devices For Cystic Fibrosis market size has reached to $2.73 billion in 2025 • Expected to grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: Rising Prevalence Of Lung Disorders To Drive Growth In Market • Market Trend: Enhancing User Experience Through Innovative Design In Airway Clearance Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Airway Clearance Devices For Cystic Fibrosis Market?

Airway clearance devices for cystic fibrosis are medical tools designed to help clear mucus from the lungs, improving respiratory function and reducing the risk of lung infections. They are primarily used to manage respiratory symptoms, enhance lung function, and improve the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions. The main device types of airway clearance devices for cystic fibrosis are vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other airway clearance devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. The patient types include adults with cystic fibrosis and pediatric patients with cystic fibrosis. The end users of these devices are hospitals and clinics, home healthcare settings, and other end users.

What Is The Airway Clearance Devices For Cystic Fibrosis Market Growth Forecast?

The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing focus on personalized respiratory care, rising adoption of connected respiratory devices, expansion of telehealth-supported cf management, growing demand for lightweight and portable systems, increasing investments in respiratory device innovation. Major trends in the forecast period include increasing adoption of portable airway clearance devices, growing demand for home-based respiratory care solutions, rising use of wearable chest oscillation systems, expansion of pediatric-specific device designs, enhanced focus on patient comfort and compliance.

Global Airway Clearance Devices For Cystic Fibrosis Market Segmentation

1) By Device Type: Vest Systems, Intrapulmonary Percussive Ventilators (IPV), Positive Expiratory Pressure (PEP) Devices, High-Frequency Chest Wall Oscillation (HFCWO) Devices, Other Airway Clearance Devices 2) By Patient Type: Adults With Cystic Fibrosis, Pediatric Patients With Cystic Fibrosis 3) By End User: Hospitals And Clinics, Home Healthcare Settings, Other End Users Subsegments: 1) By Vest Systems: Pneumatic Vest Systems, Electrical Vest Systems 2) By Intrapulmonary Percussive Ventilators (IPV): Manual IPV Devices, Automatic IPV Devices 3) By Positive Expiratory Pressure (PEP) Devices: Single-Use PEP Devices, Reusable PEP Devices 4) By High-Frequency Chest Wall Oscillation (HFCWO) Devices: Portable HFCWO Devices, Hospital-Grade HFCWO Devices 5) By Other Airway Clearance Devices: Oscillating Positive Expiratory Pressure (OPEP) Devices, Mechanical Insufflation-Exsufflation Devices

What Is The Driver Of The Airway Clearance Devices For Cystic Fibrosis Market?

The increasing prevalence of lung disorders is expected to propel the growth of the airway clearance devices for cystic fibrosis market going forward. Lung disorders refer to conditions that lead to excessive mucus production and impaired lung function, creating a rising demand for effective solutions to clear airways and improve respiratory health. The increasing prevalence of lung disorders can be attributed to several interrelated factors, including rising air pollution and smoking and tobacco use, both of which contribute significantly to respiratory diseases and long-term lung damage. Airway clearance devices, such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices, help break up and clear thick mucus from the airways, which is especially important for cystic fibrosis patients whose abnormally thick and sticky mucus leads to chronic lung infections and breathing difficulties. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Therefore, increasing prevalence of lung disorders will drive the airway clearance devices for cystic fibrosis industry.

Key Players In The Global Airway Clearance Devices For Cystic Fibrosis Market

Major companies operating in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare

Global Airway Clearance Devices For Cystic Fibrosis Market Trends and Insights

Major companies operating in the airway clearance devices for cystic fibrosis market are focusing on technological advancements such as high-frequency chest wall oscillation technology to enhance the effectiveness of mucus clearance, improve patient comfort, reduce treatment time, and provide non-invasive, at-home treatment options, ultimately leading to better clinical outcomes and quality of life for cystic fibrosis patients. High-frequency chest wall oscillation technology is a therapeutic technique that uses rapid air pulses to create vibrations on the chest wall, helping to loosen and mobilize mucus for easier removal from the lungs. For instance, in September 2024, Baxter International Inc., a US-based healthcare company, launched its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System retains the reliable airflow technology of the previous version while incorporating improved comfort and patient-focused features informed by feedback from both clinicians and patients. It is designed to assist with daily therapy for adults and children with specific chronic lung conditions and retained secretions.

What Are Latest Mergers And Acquisitions In The Airway Clearance Devices For Cystic Fibrosis Market?

In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. With this acquisition Inogen aims to expand its respiratory care portfolio by addressing the growing and underserved airway clearance market, particularly through the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS is a France-based medical technology company specializing in airway clearance and mucus management devices.

Regional Outlook

North America was the largest region in the airway clearance devices for cystic fibrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Airway Clearance Devices For Cystic Fibrosis Market?

The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.